Search alternatives:
values decrease » values increased (Expand Search), largest decrease (Expand Search)
cases increased » rate increased (Expand Search), levels increased (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
ct cases » c2 cases (Expand Search), chd cases (Expand Search), ckd cases (Expand Search)
values decrease » values increased (Expand Search), largest decrease (Expand Search)
cases increased » rate increased (Expand Search), levels increased (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
ct cases » c2 cases (Expand Search), chd cases (Expand Search), ckd cases (Expand Search)
-
1
-
2
-
3
S1 File -
Published 2024“…In addition to the CT value of ≥27.7 HU, PMCT findings of solid-natured gastrointestinal content and intra/peri-content bubbles ≥4 mm, extracted from the derivation set, increased the specificity for UGIB (96.5% and 98.8%, respectively) but decreased the sensitivity (61.5% and 38.5%, respectively) in the validation set. …”
-
4
Table 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
5
Image 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
6
Table 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
7
Image 2_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
8
Table 3_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
9
Image 1_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
10
Image 8_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
11
Image 6_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
12
Image 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tif
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
13
Image 7_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
14
Image 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.tiff
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
15
Table 4_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
16
Table 5_Relations between neurometabolism and clinical biomarkers in patients with metabolic disease.xlsx
Published 2025“…In this study, we analyzed PET-CT images and clinical biomarkers from 112 cases of hypertension, 56 cases of T2DM, 11 cases of obesity, and 14 cases of gout. …”
-
17
-
18
-
19
Role of the Trifluoropropynyl Ligand in Blue-Shifting Charge-Transfer States in Emissive Pt Diimine Complexes and an Investigation into the PMMA-Imposed Rigidoluminescence and Rigi...
Published 2022“…The trifluoropropynyl ligand elevates the energy of the MLCT and LL’CT states above that of the IL π–π* state, resulting in IL emission in all cases. …”
-
20
DataSheet_1_Level-Specific Volumetric BMD Threshold Values for the Prediction of Incident Vertebral Fractures Using Opportunistic QCT: A Case-Control Study.pdf
Published 2022“…</p>Materials and Methods<p>In this case-control study, 35 incident VF cases (23 women, 12 men; mean age: 67 years) and 70 sex- and age-matched controls were included, based on routine multi detector CT (MDCT) scans of the thoracolumbar spine. …”